Development of a monoclonal antibody capable of differentiating platelet PLA1/PLA1, PLA1/PLA2 and PLA2/PLA2 genotypes
- PMID: 1520609
- DOI: 10.1111/j.1365-2141.1992.tb08182.x
Development of a monoclonal antibody capable of differentiating platelet PLA1/PLA1, PLA1/PLA2 and PLA2/PLA2 genotypes
Abstract
A monoclonal antibody, LK-4, has been developed which distinguishes platelet PLA1/PLA1, PLA1/PLA2 and PLA2/PLA2 genotypes on platelet glycoprotein GPIIIa of Triton-solubilized platelet extracts. An ELISA assay has been developed which traps GPIIIa with Concanavalin A, enriching the platelet extract for the PLA antigens. A second monoclonal antibody, DEK-10, which reacts equally with GPIIIa of PLA1/PLA1 and PLA2/PLA2 platelet extracts is employed as an internal standard to correct for individual differences in GPIIIa content, GPIIIa extracted by Triton X-100 and GPIIIa trapped with Concanavalin A. This ELISA assay clearly differentiated 11 different PLA1/PLA1 subjects from eight PLA2/PLA2 women with a history of neonatal alloimmune thrombocytopenia as well as six unrelated obligate heterozygotes and should be useful in evaluating the PLA genotype of pregnant women and their families.
Similar articles
-
A monoclonal antibody (LK-4) which differentiates PLA1 from PLA2 platelet extracts but not intact platelets.Thromb Res. 1992 May 15;66(4):309-20. doi: 10.1016/0049-3848(92)90281-e. Thromb Res. 1992. PMID: 1384161
-
The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing.J Clin Invest. 1989 May;83(5):1778-81. doi: 10.1172/JCI114082. J Clin Invest. 1989. PMID: 2565345 Free PMC article.
-
A 13-mer peptide straddling the leucine33/proline33 polymorphism in glycoprotein IIIa does not define the PLA1 epitope.Blood. 1991 May 1;77(9):1964-9. Blood. 1991. PMID: 1708295
-
[Anti PLA or anti HPA-1 platelet allo-immunization].Presse Med. 1991 Nov 30;20(41):2099-103. Presse Med. 1991. PMID: 1837135 Review. French.
-
PlA2, a variant of GPIIIa implicated in coronary thromboembolic complications.J Am Coll Cardiol. 2000 Jul;36(1):90-3. doi: 10.1016/s0735-1097(00)00710-5. J Am Coll Cardiol. 2000. PMID: 10898418 Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous